MedTrace Logo

Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection

NCT04441372 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-10-01

No results posted yet for this study

Summary

Note that this is a study that is co-sponsored by Medecins Sans Frontieres, Spain, and the University of Oxford.

The primary objective of this study is to identify clinical and biochemical prognostic markers in adults with virologically confirmed COVID-19 who do not require oxygen supplementation, with a focus on: aiding safe discharge from a healthcare facility (i.e. a high NPV); near-term impact on COVID-19 interventions in resource-limited settings (i.e. simple clinico-demographic variables and biochemical markers for which near-patient / POCTs are commercially available or in late-stage development).

The secondary objective of this study is to evaluate the field-based performance of near-patient lateral flow assays for suPAR and IL-6 in adults with non-severe SARS-CoV-2 infection

Conditions

Sponsors & Collaborators

  • Mahidol Oxford Tropical Medicine Research Unit

    collaborator OTHER

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER

  • Foundation for Innovative New Diagnostics, Switzerland

    collaborator OTHER

  • Medecins Sans Frontieres, Spain

    lead OTHER

Principal Investigators

  • Arjun Chandna, MD · Cambodia Oxford Medical Research Unit

  • Sakib Burza, PhD · Medecins Sans Frontieres, Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Brazil
  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04441372 on ClinicalTrials.gov